INVENTURUS KNOWLEDGE SOLUTIONS LIMITED — Board/Management Information 2025

Jul 31, 2025

August 1, 2025

BSE Limited National Stock Exchange of India Limited The Listing Department The Listing Department Phiroze Jeejeebhoy Towers Exchange Plaza, Plot No. C/1, G Block, 25[th] Floor, Dalal Street Bandra Kurla Complex Fort, Mumbai 400 001 Bandra (East), Mumbai 400051 Maharashtra, India Maharashtra, India BSE Scrip Code: 544309 NSE Symbol: IKS

Dear Sir/Ma’am,

Sub: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Change in Directorate

Pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( “SEBI Listing Regulations” ) and SEBI Master circular SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11 November 2024, we hereby inform that the Board of Directors of the Company at its meeting held on July 31, 2025, inter alia , approved the following:

1. Inventurus Knowledge Solutions Inc, USA has designated Mr. Sachin Gupta as Global CEO: The Board noted that Mr. Sachin Gupta has been designated as Global CEO of Inventurus Knowledge Solutions Inc, USA, wholly owned subsidiary of the Company .

2. Appointment of Mr. Sachin Gupta as an Additional Director (Non-Executive, Non-Independent) of the Company:

The Board of Directors, based on the recommendation of the Nomination and Remuneration Committee, has considered and approved appointment of Mr. Sachin Gupta (DIN: 02239277) as an Additional Director (Non-Executive, Non-Independent), liable to retire by rotation, w.e.f. August 1, 2025, subject to approval of shareholders.

Further, Mr. Sachin Gupta has also confirmed that he is not debarred from holding the office of Director by virtue of any SEBI order or any other such authority.

The disclosure under Regulation 30 read with Schedule III of the SEBI Listing Regulations for this matter is enclosed as “Annexure – A”.

3. Resignation of Mr. Sachin Gupta as a Whole-time Director of the Company:

Mr. Sachin Gupta (DIN: 02239277), Whole-time Director of the Company has tendered his resignation from the position of the Whole-time Director of the Company with effect from close of business hours on July 31, 2025. The disclosure under Regulation 30 read with Schedule III of the SEBI Listing Regulations for this matter is enclosed as “Annexure-B”. The letter of resignation received from Mr. Sachin Gupta along with the confirmation that there are no material reasons for his resignation other than those mentioned therein is enclosed as “Annexure-C”.

4. Appointment of Ms. Nithya Balasubramanin, CFO (KMP of the Company), as an Additional Director (Whole- time Director) on the Board of the Company:

The Board of Directors based on the recommendation of the Nomination and Remuneration Committee, has considered and approved appointment of Ms. Nithya Balasubramanian (DIN: 10664861) as an Additional Director (Whole-time Director) on the Board of the Company, for a term of 5 years from August 1, 2025 to July 31, 2030 (both days inclusive) subject to approval by the shareholders of the Company.

Further, Ms. Nithya Balasubramanian has also confirmed that she is not debarred from holding the office of Director by virtue of any SEBI order or any other such authority.

The disclosure under Regulation 30 read with Schedule III of the SEBI Listing Regulations for this matter is enclosed as “Annexure – D”

5. Appointment of Mr. Garheng Albert Kong (DIN: 11218828), as Additional Director (Non-Executive, Independent) on the Board of the Company:

The Board of Directors, based on the recommendation of the Nomination and Remuneration Committee, has considered and approved appointment of Mr. Garheng Albert Kong (DIN: 11218828) as an Additional Director (Non-Executive, Independent) on the Board of the Company, for a term of 5 years from August 1, 2025 to July 31, 2030 (both days inclusive) subject to approval by the shareholders of the Company.

Further, Mr. Garheng Albert Kong has also confirmed that he is not debarred from holding the office of Director by virtue of any SEBI order or any other such authority.

The disclosure under Regulation 30 read with Schedule III of the SEBI Listing Regulations for this matter is enclosed as “Annexure – E”

We request you to take the same on your records

Yours sincerely,

For Inventurus Knowledge Solutions Limited

Sameer Digitally signed by Sameer Shashikant Shashikant Chavan Date: 2025.08.01 Chavan 00:31:55 +05'30'

Sameer Chavan Company Secretary and Compliance Officer Membership No. F7211

Encl: As above

Annexure – A

Disclosure with respect to the appointment of Mr. Sachin Gupta as an Additional Director (NonExecutive, Non-Independent) of the Company:

Sr. No.		Particulars	Details
1.		Name of the Director	Mr. Sachin Gupta
2.		Reason for change viz. appointment, ~~resignation,~~ ~~removal, death or otherwise~~	The Board of Directors has appointed Mr. Sachin Gupta as an Additional Director (Non-Executive, Non-Independent), liable to retire by rotation w.e.f. August 1, 2025, subject to approval of shareholders.
3.		Date of appointment/ ~~cessation (as applicable) &~~ ~~term of appointment~~	Date of appointment: August 1, 2025 Term of appointment: Liable to retire by rotation.
4.		Brief Profile (in case of appointment)	Mr. Sachin Gupta is a Founder and one of the Promoter of the Company. He is the Global CEO of Inventurus Knowledge Solutions Inc. He holds a bachelor’s degree in engineering (computer) from the University of Pune. He is also a member of the Young Presidents’ Organisation. He has over 17 years of experience in business management. In the past, he has been associated with Seletica Configurators India Private Limited, Majoris Systems Private Limited and Lionbridge Technologies, Inc. and has prior experience in software and business development.
5.		Disclosure of relationships between directors (in case of appointment of a director)	Mr. Sachin Gupta is not related to any of the Directors of the Company.

Annexure – B

Disclosure with respect to the resignation of Mr. Sachin Gupta from the post of Whole-time Director of the Company:

Sr. No.		Particulars	Details
1.		Name of the Director	Mr. Sachin Gupta
2.		Reason for change viz. ~~appointment,~~ resignation, ~~removal, death or otherwise~~	Mr. Sachin Gupta has tendered his resignation as a Whole- time Director of the Company, due to his personal reasons.
		~~,~~
3.		Date of ~~appointment/~~ cessation~~(as applicable) &~~ ~~term of appointment~~	With effect from close of business hours on July 31, 2025.
4.		Brief Profile (in case of appointment)	Not applicable.
5.		Disclosure of relationships between directors (in case of appointment of a director)	Not applicable.

Annexure - C

Annexure – D

Disclosure with respect to the appointment of Ms. Nithya Balasubramanin, CFO (Key Managerial Personnel of the Company), as an Additional Director (Whole-time Director) on the Board of the Company

Company
Sr. No.		Particulars	Details
1.		Name of the Director	Ms. Nithya Balasubramanian
2.		Reason for change viz. appointment, ~~resignation,~~ ~~removal, death or otherwise~~	The Board of Directors have appointed Ms. Nithya Balasubramanian as an Additional Director (Whole-time Director), w.e.f. August 1, 2025, subject to approval of shareholders. Ms. Nithya Balasubramanian continued to be Chief Financial Officer of the Company.
3.		Date of appointment/ ~~cessation (a~~s applicable) & term of appointment	Date of appointment: Date of appointment as Additional Director (Whole-time Director) with effect from August 1, 2025. Term of appointment: For a term of 5 years from August 1, 2025 to July 31, 2030 (both days inclusive) subject to approval bythe shareholders of the Company.
4.		Brief Profile (in case of appointment)	Ms. Nithya Balasubramanian holds a bachelor’s degree of engineering in electrical and electronical engineering from the Birla University of Technology & Science, Rajasthan, and a post graduate diploma in management from Indian Institute of Management, Bangalore. She has over 17 years of experience in the field of corporate finance and equities research. She has previously worked with McKinsey & Company, Inc as their engagement manager, Cipla Limited as their vice president and Alliance Bernstein Business Services Private Limited as their vice president/director, senior research analyst.
5.		Disclosure of relationships between directors (in case of appointment of a director)	Ms. Nithya Balasubramanian is not related to any of the Directors of the Company.

Annexure - E

Disclosure with respect to the appointment of Mr. Garheng Albert Kong (DIN: 11218828), as Additional Director (Non-Executive, Independent) on the Board of the Company:

Sr. No.		Particulars	Details
1.		Name of the Director	Mr. Garheng Albert Kong
2.		Reason for change viz. appointment, ~~resignation,~~ ~~removal, death or otherwise~~	Appointment of Mr. Garheng Albert Kong (DIN: 11218828), as Additional Director (Non-Executive, Independent) of the Company.
3.		Date of appointment/ ~~cessation (as applicable) &~~ term of appointment	Date of appointment: Date of appointment as Additional Director (Non- Executive, Independent) with effect from August 1, 2025. Term of appointment: For a term of 5 years from August 1, 2025 to July 31, 2030 (both days inclusive) subject to approval bythe shareholders of the Company.
4.		Brief Profile (in case of appointment)	Mr. Garheng Albert Kong is a physician, scientist, and engineer by training. He has over two decades of experience investing in innovative healthcare companies with a long list of successes (36 IPO/M&A exits). He founded HealthQuest Capital in 2012 to improve people’s lives through improving healthcare on a significant scale. His vision was to build a best- in-class team of the highest talent and integrity to work with outstanding entrepreneurs to transform healthcare through high growth companies while generating outsized risk adjusted returns for investors. His interests and industry footprint are broad as he serves as the Lead Independent Director of LabCorp (LH) and serves on the board of Xeris Biopharma (XERS), Be the Match, Duke University Health System, Duke University Board of Trustees, Dell Children’s Foundation, UT President’s Commercial Advisory Board, and the Austin Healthcare Council, and has served as Chairman on 11 Boards. He is an Aspen Institute Health Innovators Fellow, Kauffman Fellows Mentor, and member of YPO. Mr. Kong was named a Top 25 Healthcare Investor by Growth Cap in 2022, 2024 and 2025, and received their Healthcare Investor of the Year award for 2024 (presented in March 2025). In 2023, he was also recognized by Board Prospects as one of the Top 30 Asian American and Pacific Islander Board Members in the U.S. He has received undergraduate degrees in both Chemical Engineering and Biological Sciences from Stanford, while on an athletic scholarship. He then earned a MD,PhD and MBA

			from Duke University, graduating at the top of his class in each instance. His early career included stints at GlaxoSmithKline, McKinsey and a medical device start-up, TherOx, before joining Intersouth Partners and then Sofinnova Investments. Mr. Garheng Albert Kong is not related to any of the Directors of the Company.
			from Duke University, graduating at the top of his class in each instance. His early career included stints at GlaxoSmithKline, McKinsey and a medical device start-up, TherOx, before joining Intersouth Partners and then Sofinnova Investments.
	5.	Disclosure of relationships between directors (in case of appointment of a director)	Mr. Garheng Albert Kong is not related to any of the Directors of the Company.